Astex Pharmaceuticals, Inc. (ASTX) Posts Surprise Q2 Profit
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts ASTX Hot Sheet
Join SI Premium – FREE
Astex Pharmaceuticals, Inc. (NASDAQ: ASTX) reported Q2 EPS of $0.01, $0.08 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $19.9 million versus the consensus estimate of $15.5 million.
For earnings history and earnings-related data on Astex Pharmaceuticals, Inc. (ASTX) click here.
For earnings history and earnings-related data on Astex Pharmaceuticals, Inc. (ASTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Oriental Education (EDU) Misses Q1 EPS by 11c; Offers Guidance
- Materialise NV (MTLS) Reports In-Line Q3 EPS; reaffirms outlook
- Banco Santander S.A. (SAN) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
